Medicare Rx Sales Effort Has Ground To Cover, Focus Groups Suggest
Executive Summary
The pharmaceutical industry faces an uphill battle to "sell" the Medicare law to beneficiaries, research sponsored by the Kaiser Family Foundation suggests
You may also be interested in...
Medicare Rx Card “Rejected” By Seniors, Dems Say, Citing Low Enrollment
Low enrollment in Medicare-endorsed drug discount cards indicates that seniors have "rejected" the program, Senate Minority Leader Tom Daschle (D-S.D.) maintained
Medicare Rx Card “Rejected” By Seniors, Dems Say, Citing Low Enrollment
Low enrollment in Medicare-endorsed drug discount cards indicates that seniors have "rejected" the program, Senate Minority Leader Tom Daschle (D-S.D.) maintained
Rx Industry Will Sell Medicare Bill; Card Launch Will Be First Test
PhRMA's efforts to support the roll-out of the Medicare prescription drug benefit will begin with the use of industry sales reps to deliver educational material, incoming Pharmaceutical Research & Manufacturers of America Chairman Miles White (Abbott) told the association's annual meeting in Palm Beach, Fla. April 3